147 related articles for article (PubMed ID: 34282441)
1. Clinical significance of anti-NOR90 antibodies in systemic sclerosis and idiopathic interstitial pneumonia.
Yamashita Y; Yamano Y; Muro Y; Ogawa-Momohara M; Takeichi T; Kondoh Y; Akiyama M
Rheumatology (Oxford); 2022 Apr; 61(4):1709-1716. PubMed ID: 34282441
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review.
Dima A; Vonk MC; Garaiman A; Kersten BE; Becvar R; Tomcik M; Hoffmann-Vold AM; Castellvi I; Jaime JT; Brzosko M; Milchert M; Krasowska D; Michalska-Jakubus M; Airo P; Matucci-Cerinic M; Bruni C; Iudici M; Distler J; Gheorghiu AM; Poormoghim H; Motta F; De Santis M; Parvu M; Distler O; Mihai C
Eur J Intern Med; 2024 Jul; 125():104-110. PubMed ID: 38599922
[TBL] [Abstract][Full Text] [Related]
3. Comparison of nintedanib-induced gastrointestinal adverse events between patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias.
Imai M; Okabayashi H; Akaike K; Hamada S; Masunaga A; Ichiyasu H; Sakagami T
Respir Investig; 2024 May; 62(3):317-321. PubMed ID: 38395006
[TBL] [Abstract][Full Text] [Related]
4. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
Chong WH; Saha BK; Beegle S
Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
[TBL] [Abstract][Full Text] [Related]
5. Utility of Anti-DSF70 Antibodies to Predict Connective Tissue Disease in Patients Originally Presenting with Idiopathic Interstitial Pneumonia.
Lyu Y; Boerner E; Theegarten D; Guzman J; Kreuter M; Costabel U; Bonella F
Respiration; 2019; 98(1):29-37. PubMed ID: 30928980
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852
[TBL] [Abstract][Full Text] [Related]
7. Disease-related autoantibody profile in patients with systemic sclerosis.
Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients.
Wu M; Assassi S; Salazar GA; Pedroza C; Gorlova OY; Chen WV; Charles J; Taing ML; Liao K; Wigley FM; Hummers LK; Shah AA; Hinchcliff M; Khanna D; Schiopu E; Phillips K; Furst DE; Steen V; Baron M; Hudson M; Zhou X; Pope J; Jones N; Docherty P; Khalidi NA; Robinson D; Simms RW; Silver RM; Frech TM; Fessler BJ; Fritzler MJ; Molitor JA; Segal BM; Movahedian M; Martín J; Varga J; Mayes MD
Arthritis Res Ther; 2016 Jan; 18():20. PubMed ID: 26792595
[TBL] [Abstract][Full Text] [Related]
9. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features and Risk Factors of Rapidly Progressive Systemic Sclerosis in a Single Center in China: Anti-RNA Polymerase III Antibodies as a Predictor.
Yu Q; Zhang J; Fan L; Yu T; Liu B; Ding J
Discov Med; 2023 Apr; 35(175):193-200. PubMed ID: 37105929
[TBL] [Abstract][Full Text] [Related]
11. Ability of the COPD Assessment Test to evaluate the lung-specific quality of life in systemic sclerosis-associated interstitial lung disease.
Mugii N; Someya F
Clin Respir J; 2020 Jun; 14(6):527-532. PubMed ID: 32045097
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic options for systemic sclerosis related interstitial lung diseases.
Mouthon L; Bérezné A; Guillevin L; Valeyre D
Respir Med; 2010 Jul; 104 Suppl 1():S59-69. PubMed ID: 20630349
[TBL] [Abstract][Full Text] [Related]
13. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Venezuelan patients with systemic sclerosis: a study in a tertiary hospital in Caracas.
Rivas-Vargas D; Snih SA; Rodríguez MA
Reumatol Clin (Engl Ed); 2021 Dec; 17(10):601-606. PubMed ID: 34823828
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy and predictive value of autoantibody profiles in patients with systemic sclerosis: a single-center study.
Zhang X; Zhang H; Zhao J; Li Y; Wang H; Li C
Clin Rheumatol; 2023 May; 42(5):1297-1306. PubMed ID: 36604358
[TBL] [Abstract][Full Text] [Related]
16. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
[TBL] [Abstract][Full Text] [Related]
17. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
18. [Interstitial lung disease in systemic sclerosis].
Mouthon L; Berezné A; Brauner M; Kambouchner M; Guillevin L; Valeyre D
Rev Mal Respir; 2007 Oct; 24(8):1035-46. PubMed ID: 18033190
[TBL] [Abstract][Full Text] [Related]
19. [The clinical features and prognosis of interstitial lung disease patients with positive anti-neutrophil cytoplasmic antibody].
Gao C; Sun X; Huang J; Peng M; Sun XF; Zhang T; Shi JH
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):362-368. PubMed ID: 32294819
[No Abstract] [Full Text] [Related]
20. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease.
Fischer A; Meehan RT; Feghali-Bostwick CA; West SG; Brown KK
Chest; 2006 Oct; 130(4):976-81. PubMed ID: 17035427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
